Novo Nordisk shares fell 30% in the fourth quarter on disappointing clinical trial data, concerns about its experimental ...

The words were shared under a sweet photo of a pregnancy album with two positive pregnancy tests, two ultrasound scans, and a ...

Investing.com - Novo Nordisk (CSE: NOVOb ) remains the "most exciting growth story" in the European pharmaceutical sector and ...

By comparison, the FDA-approved drug liraglutide only resulted in just under 6% weight loss after 26 weeks, the researchers found. Common adverse side effects from the drugs included nausea, vomiting, ...

WATERLOO, Iowa. (KWWL) - After two years at KWWL, Lilly Cederdahl signed off for her final time Wednesday. From covering county fairs to breaking news, to tracking morning commute, she said it's been ...

Ariana Grande reunited with boyfriend Ethan Slater at the star-studded National Board of Review Annual Awards Gala in New ...

Weight-loss medication like Semaglutide and Tirzepatide has seen a rise in demand, causing a boom in sales. This exploding ...

Here are some of the drugs that are predicted to become blockbusters in the next few years, according to Clarivate's latest ...

Finbold has selected three interesting pharmaceutical stocks that could see significant moves to the upside in 2025.

Truist Financial analyst Srikripa Devarakonda maintained a Buy rating on Eli Lilly & Co (LLY – Research Report) yesterday and set a price ...

Murder suspect Giovanni Ornelas, who allegedly disabled his ankle monitor to escape a murder trial, is back behind bars. The U.S. Marshals fugitive team arrested him on Tuesday.

Neither coffee drinking pattern was tied to more or less cancer-specific mortality.